Clinical trials
Glaucoma trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
507 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 4 |
| 2005 | 11 |
| 2006 | 7 |
| 2007 | 9 |
| 2008 | 6 |
| 2009 | 13 |
| 2010 | 17 |
| 2011 | 24 |
| 2012 | 16 |
| 2013 | 17 |
| 2014 | 26 |
| 2015 | 16 |
| 2016 | 25 |
| 2017 | 24 |
| 2018 | 31 |
| 2019 | 22 |
| 2020 | 31 |
| 2021 | 32 |
| 2022 | 32 |
| 2023 | 38 |
| 2024 | 19 |
| 2025 | 32 |
| 2026 | 39 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 257 |
| Unknown status | 107 |
| Recruiting | 64 |
| Terminated | 28 |
| Not yet recruiting | 20 |
| Withdrawn | 16 |
| Active, not recruiting | 9 |
| Enrolling by invitation | 4 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wills Eye | 18 |
| Duke University | 12 |
| Sensimed AG | 11 |
| University of California, San Francisco | 10 |
| Stanford University | 9 |
| Glaukos Corporation | 7 |
| Medical University of Vienna | 7 |
| Optos, PLC | 7 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 6 |
| Johns Hopkins University | 6 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glaucoma | 507 |
| Glaucoma, Open-Angle | 89 |
| Ocular Hypertension | 49 |
| Cataract | 38 |
| Diabetic Retinopathy | 22 |
| Macular Degeneration | 21 |
| Eye Diseases | 20 |
| Glaucoma, Angle-Closure | 12 |
| Vision Disorders | 10 |
| Retinitis Pigmentosa | 9 |
Trials
Showing 51 to 75 of 507. Each trial links to its page on Pharma Observatory.
407 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.